ArchivesMagazine - 19 Apr 2018ImmuPharma collapses on trial failure Shares lose 85% of their value after failure on key lupus drug 19 April 2018|News Issue: 19 Apr 2018 - Page 10 < Cyber security firm Avast set for £2.8bn IPO JD Sports is still fighting fit > Issue: 19 Apr 2018 - Page 10 | Contents Next: JD Sports is still fighting fit Previous: Cyber security firm Avast set for £2.8bn IPO Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Lisa-Marie Janes Issue Contents Editor's View Which is more important: quality or valuation? Feature All change: How new management can be good for companies and their share price How the SOX index can help investors work out whether stock markets are going to rock or roll Funds Get ready for an important development with Chinese shares Great Ideas Out of the blue growth shock sees pressure mount on Sage SciSys looks far too cheap given its performance Filta moves into profit and hunts for acquisitions Why Croda’s seed enhancement business is providing food for thought Be brave and snap up Saga for a handsome 7% dividend yield Eddie Stobart Logistics fails to accelerate on Brexit concerns Larger Companies ASOS’s increased spending plans are not a reason to dump the shares News JD Sports is still fighting fit ImmuPharma collapses on trial failure British Airways owner eyes takeover of Norwegian Air Apollo stalks FirstGroup with takeover interest Pound pushes to highest level since Brexit vote Cyber security firm Avast set for £2.8bn IPO Activist investor Elliott rumoured to have Micro Focus in its sights Costa spin-off calls at Whitbread gain momentum Personal Finance A cut-out-and-keep guide to defined benefit pension transfers How much investment risk do I need in retirement? Smaller Companies Liontrust roars into 2019 looking like a new beast Boku set for 2018 profit breakthrough as apps store payments soar Story In Numbers Klepierre walks away from Hammerson bid and Intu deal collapses Intercede to could do with a change of growth identity Dunelm shifts growth focus to online channel Talking Point Will the next batch of US corporate earnings live up to expectations? Week Ahead Share buyback in focus ahead of Shell results Will Lloyds surprise the market again? Reckitt to restore confidence?